Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.

Leslie GJ, Wang J, Richardson MW, Haggarty BS, Hua KL, Duong J, Secreto AJ, Jordon AP, Romano J, Kumar KE, DeClercq JJ, Gregory PD, June CH, Root MJ, Riley JL, Holmes MC, Hoxie JA.

PLoS Pathog. 2016 Nov 17;12(11):e1005983. doi: 10.1371/journal.ppat.1005983. eCollection 2016 Nov.

2.

Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.

Boyd DF, Peterson D, Haggarty BS, Jordan AP, Hogan MJ, Goo L, Hoxie JA, Overbaugh J.

J Virol. 2015 Jan 15;89(2):894-907. doi: 10.1128/JVI.02680-14. Epub 2014 Nov 5.

3.

Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression.

Breed MW, Jordan AP, Aye PP, Lichtveld CF, Midkiff CC, Schiro FR, Haggarty BS, Sugimoto C, Alvarez X, Sandler NG, Douek DC, Kuroda MJ, Pahar B, Piatak M Jr, Lifson JD, Keele BF, Hoxie JA, Lackner AA.

J Virol. 2013 Feb;87(3):1528-43. doi: 10.1128/JVI.01928-12. Epub 2012 Nov 14.

4.

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Lin G, Simmons G, Pöhlmann S, Baribaud F, Ni H, Leslie GJ, Haggarty BS, Bates P, Weissman D, Hoxie JA, Doms RW.

J Virol. 2003 Jan;77(2):1337-46.

6.

Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN.

Baribaud F, Pöhlmann S, Sparwasser T, Kimata MT, Choi YK, Haggarty BS, Ahmad N, Macfarlan T, Edwards TG, Leslie GJ, Arnason J, Reinhart TA, Kimata JT, Littman DR, Hoxie JA, Doms RW.

J Virol. 2001 Nov;75(21):10281-9.

7.

The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis.

Bowers K, Pelchen-Matthews A, Höning S, Vance PJ, Creary L, Haggarty BS, Romano J, Ballensiefen W, Hoxie JA, Marsh M.

Traffic. 2000 Aug;1(8):661-74.

8.

CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2.

Molino M, Woolkalis MJ, Prevost N, Praticó D, Barnathan ES, Taraboletti G, Haggarty BS, Hesselgesser J, Horuk R, Hoxie JA, Brass LF.

Biochim Biophys Acta. 2000 Feb 21;1500(2):227-40.

9.

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.

LaBranche CC, Hoffman TL, Romano J, Haggarty BS, Edwards TG, Matthews TJ, Doms RW, Hoxie JA.

J Virol. 1999 Dec;73(12):10310-9.

10.

An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface.

Sauter MM, Pelchen-Matthews A, Bron R, Marsh M, LaBranche CC, Vance PJ, Romano J, Haggarty BS, Hart TK, Lee WM, Hoxie JA.

J Cell Biol. 1996 Mar;132(5):795-811.

11.

A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells.

LaBranche CC, Sauter MM, Haggarty BS, Vance PJ, Romano J, Hart TK, Bugelski PJ, Marsh M, Hoxie JA.

J Virol. 1995 Sep;69(9):5217-27.

12.

Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.

LaBranche CC, Sauter MM, Haggarty BS, Vance PJ, Romano J, Hart TK, Bugelski PJ, Hoxie JA.

J Virol. 1994 Nov;68(11):7665-7. No abstract available.

13.

Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.

LaBranche CC, Sauter MM, Haggarty BS, Vance PJ, Romano J, Hart TK, Bugelski PJ, Hoxie JA.

J Virol. 1994 Sep;68(9):5509-22. Erratum in: J Virol. 1994 Nov;68(11):7665-7.

14.

Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.

Hoxie JA, Brass LF, Pletcher CH, Haggarty BS, Hahn BH.

J Virol. 1991 Sep;65(9):5096-101.

15.

Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.

Kumar P, Hui HX, Kappes JC, Haggarty BS, Hoxie JA, Arya SK, Shaw GM, Hahn BH.

J Virol. 1990 Feb;64(2):890-901.

16.
17.

T4 endocytosis and phosphorylation induced by phorbol esters but not by mitogen or HIV infection.

Hoxie JA, Rackowski JL, Haggarty BS, Gaulton GN.

J Immunol. 1988 Feb 1;140(3):786-95.

PMID:
3257504
18.

Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.

Hoxie JA, Alpers JD, Rackowski JL, Huebner K, Haggarty BS, Cedarbaum AJ, Reed JC.

Science. 1986 Nov 28;234(4780):1123-7.

PMID:
3095925
19.

Infection of T4 lymphocytes by HTLV-III does not require expression of the OKT4 epitope.

Hoxie JA, Flaherty LE, Haggarty BS, Rackowski JL.

J Immunol. 1986 Jan;136(2):361-3. No abstract available.

PMID:
2416802
20.

Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus.

Hoxie JA, Haggarty BS, Rackowski JL, Pillsbury N, Levy JA.

Science. 1985 Sep 27;229(4720):1400-2.

PMID:
2994222

Supplemental Content

Loading ...
Support Center